5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine has been researched along with besipirdine in 1 studies
| Studies (5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine) | Trials (5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine) | Recent Studies (post-2010) (5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine) | Studies (besipirdine) | Trials (besipirdine) | Recent Studies (post-2010) (besipirdine) |
|---|---|---|---|---|---|
| 10 | 0 | 1 | 15 | 3 | 1 |
| Protein | Taxonomy | 5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine (IC50) | besipirdine (IC50) |
|---|---|---|---|
| Tissue alpha-L-fucosidase | Homo sapiens (human) | 0.25 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 2.1644 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 2.3133 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 2.3133 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 2.3133 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 2.3133 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 10 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.295 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.295 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.295 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 10 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anger, T; Madge, DJ; Mulla, M; Riddall, D | 1 |
1 review(s) available for 5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine and besipirdine
| Article | Year |
|---|---|
Medicinal chemistry of neuronal voltage-gated sodium channel blockers.
Topics: Amyotrophic Lateral Sclerosis; Analgesics; Anticonvulsants; Epilepsy; Humans; Ion Channel Gating; Models, Molecular; Mutation; Nerve Tissue Proteins; Neuroprotective Agents; Protein Binding; Sodium Channel Blockers; Sodium Channels; Stroke | 2001 |